Please find attached herewith Disclosure under Regulation 30 of the SEBI (LODR) Regulation 2015.

30th July, 2026 The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, In compliance with Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has dispatched letters providing the web-link including the exact path to access the Annual Report for FY 2025-26 of Company to those shareholders who have not registered their email addresses with the Company or the Depository Participants (“DPs”) or the Registrar to an Issue & Share Transfer Agent (“RTA”). A draft copy of the same is enclosed for reference. The same is also available on the website of the Company at www.alkemlabs.com Kindly take the same on record. Thanking you Sincerely, For Alkem Laboratories Limited Divya Mewani Vice President – Legal and Deputy Company Secretary Encl: a/a ALKEM LABORATORIES LIMITED CIN: L00305MH1973PLC174201 Registered Office: ‘Alkem House’, Senapati Bapat Marg, Lower Parel, Mumbai 400 013. Phone: +91 22 3982 9999; Fax: +91 22 2495 2955 Website: www.alkemlabs.com Email: investors@alkem.com Sr.No. :- 1 Date : July 30, 2026 INDU JAIN Folio No./DP-CLID : XXXXXXXXXXXX6903 HOUSE NO-100, BABAR ROAD, OPP. HOTEL LALIT CONNAUGHT PLACE NEW DELHI 110001 Dear Shareholder, Sub.: Notice of 52nd Annual General Meeting (AGM) of M/s. Alkem Laboratories Limited and Annual Report for Financial Year 2025-26. We are pleased to inform you that the 52nd Annual General Meeting ('AGM') of the members of M/s. Alkem Laboratories Limited (‘the Company’) is scheduled to be held on Thursday, 27th August, 2026 at 11.00 A.M (IST) through Video Conferencing ('VC') facility / Other Audio Visual Means ('OAVM'). As per Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the web-link, including the exact path, where complete details of the Annual Report are available is required to be sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or MUFG Intime India Private Limited (formerly Link Intime India Private Limited), Registrar to an Issue & Share Transfer Agent (RTA) of the Company. Accordingly, the web-link, including the exact path where complete details of the Annual Report for Financial Year 2025- 26 are available at: Website: https://www.alkemlabs.com Exact path of Annual Report 2025-26: https://www.alkemlabs.com/investors/annual-reports This letter is being sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or RTA of the Company as on the cut-off date as on Friday, 10th July, 2026. Should you have any queries, please feel free to contact our investor relations department at investors@alkem.com or 022 3982 9999. Moreover, you are also requested to update your email address at the earliest either through your depository participants for electronic holding or send a communication to us / our RTA to facilitate the updation to continue receiving all important information & documents thereafter and encourage Green Initiative. Thanking you, Yours faithfully, For Alkem Laboratories Limited Divya Mewani VP – Legal & Deputy Company Secretary